Astera Labs (NASDAQ:ALAB) Shares Down 2.4% on Insider Selling

Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) was down 2.4% during mid-day trading on Thursday following insider selling activity. The company traded as low as $211.28 and last traded at $211.60. 4,881,128 shares changed hands during trading, a decline of 5% from the average daily volume of 5,135,559 shares. The stock had previously closed at $216.75.

Specifically, CEO Jitendra Mohan sold 96,089 shares of the stock in a transaction dated Monday, November 16th. The stock was sold at an average price of $206.62, for a total value of $19,853,909.18. Following the completion of the sale, the chief executive officer directly owned 1,170,576 shares in the company, valued at $241,864,413.12. This represents a 7.59% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Sanjay Gajendra sold 96,089 shares of Astera Labs stock in a transaction that occurred on Monday, November 16th. The shares were sold at an average price of $206.62, for a total value of $19,853,909.18. Following the completion of the sale, the chief operating officer directly owned 1,022,949 shares in the company, valued at approximately $211,361,722.38. This represents a 8.59% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In other Astera Labs news, General Counsel Philip Mazzara sold 4,380 shares of the firm’s stock in a transaction that occurred on Monday, November 16th. The stock was sold at an average price of $206.62, for a total value of $904,995.60. Following the completion of the transaction, the general counsel directly owned 92,190 shares in the company, valued at $19,048,297.80. This trade represents a 4.54% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Wall Street Analyst Weigh In

Several research analysts have weighed in on ALAB shares. Zacks Research cut shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, October 5th. Roth Capital reaffirmed a “buy” rating and set a $450.00 target price on shares of Astera Labs in a report on Wednesday, August 5th. UBS Group cut their price target on Astera Labs from $300.00 to $290.00 and set a “neutral” rating for the company in a research note on Wednesday, November 4th. Northland Securities upgraded Astera Labs from a “market perform” rating to an “outperform” rating and set a $315.00 price objective on the stock in a research note on Wednesday, November 4th. Finally, Weiss Ratings cut Astera Labs from a “buy (b-)” rating to a “hold (c)” rating in a report on Friday, October 23rd. Twelve research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat, Astera Labs has a consensus rating of “Moderate Buy” and an average price target of $325.89.

Read Our Latest Report on ALAB

Astera Labs Stock Performance

The stock’s fifty day moving average price is $285.19 and its two-hundred day moving average price is $258.24. The company has a market cap of $31.39 billion, a P/E ratio of 71.55 and a beta of 3.85.

Astera Labs (NASDAQ:ALAB – Get Free Report) last announced its quarterly earnings data on Tuesday, November 3rd. The company reported $1.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.19 by $0.13. Astera Labs had a net margin of 29.64% and a return on equity of 25.35%. The business had revenue of $584.90 million for the quarter, compared to analysts’ expectations of $550.78 million. During the same period last year, the firm posted $0.49 earnings per share. The firm’s quarterly revenue was up 153.6% compared to the same quarter last year. On average, equities research analysts forecast that Astera Labs, Inc. will post 2.99 EPS for the current year.

Hedge Funds Weigh In On Astera Labs

Several hedge funds and other institutional investors have recently modified their holdings of ALAB. Keating Financial Advisory Services Inc. purchased a new position in Astera Labs during the second quarter worth about $25,000. Archer Investment Corp bought a new stake in shares of Astera Labs in the second quarter valued at $30,000. Transamerica Financial Advisors LLC bought a new stake in shares of Astera Labs in the second quarter valued at $35,000. Continuum Advisory LLC purchased a new position in shares of Astera Labs during the 2nd quarter valued at $37,000. Finally, GK Wealth Management LLC purchased a new position in shares of Astera Labs during the 3rd quarter valued at $29,000. Institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

(Get Free Report)

Astera Labs, Inc. is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems. The company’s portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.

Featured Articles

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.